메뉴 건너뛰기




Volumn 30, Issue 10, 2007, Pages 883-889

An analysis of vigimed, a global E-mail system for the exchange of pharmacovigilance information

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANOREXIGENIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOBESITY AGENT; ANTIRETROVIRUS AGENT; ANTIRHEUMATIC AGENT; CARBOPLATIN; CYCLOOXYGENASE 2 INHIBITOR; EXCIPIENT; FLUTAMIDE; GROWTH HORMONE; HERBACEOUS AGENT; MERCURY DERIVATIVE; NEW DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PACLITAXEL; PSYCHOTROPIC AGENT; SIBUTRAMINE; THIOMERSAL; VACCINE;

EID: 34748892910     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730100-00006     Document Type: Article
Times cited : (8)

References (5)
  • 1
    • 0033376337 scopus 로고    scopus 로고
    • Pharmacovigilance in perspective
    • Meyboom RH, Egberts AC, Gribnau FW, et al. Pharmacovigilance in perspective. Drug Saf 1999; 21 (6): 429-47
    • (1999) Drug Saf , vol.21 , Issue.6 , pp. 429-447
    • Meyboom, R.H.1    Egberts, A.C.2    Gribnau, F.W.3
  • 2
    • 0031903233 scopus 로고    scopus 로고
    • The role of the WHO programme on international drug monitoring in coordinating worldwide drug safety efforts
    • Olsson S. The role of the WHO programme on international drug monitoring in coordinating worldwide drug safety efforts. Drug Saf 1998; 19 (1): 1-10
    • (1998) Drug Saf , vol.19 , Issue.1 , pp. 1-10
    • Olsson, S.1
  • 3
    • 85039103797 scopus 로고    scopus 로고
    • Uppsala Monitoring Centre, online, Available from URL:, Accessed Jun 1
    • Uppsala Monitoring Centre. WHO programme [online]. Available from URL: http://www.who-umc.org/ [Accessed 2007 Jun 1]
    • (2007) WHO programme
  • 4
    • 0029912661 scopus 로고    scopus 로고
    • Characteristics of topics in pharmacovigilance in The Netherlands
    • Meyboom RHB, Gribnau FWJ, Hekster YA, et al. Characteristics of topics in pharmacovigilance in The Netherlands. Clin Drug Invest 1996; 12 (4): 207-19
    • (1996) Clin Drug Invest , vol.12 , Issue.4 , pp. 207-219
    • Meyboom, R.H.B.1    Gribnau, F.W.J.2    Hekster, Y.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.